Wohlford, G. F., Buckley, L. F., Kadariya, D., Park, T., Chiabrando, J. G., Carbone, S., . . . Tassell, B. V. A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers. Public Library of Science (PLoS).
Chicago Style (17th ed.) CitationWohlford, George F., et al. A Phase 1 Clinical Trial of SP16, a First-in-class Anti-inflammatory LRP1 Agonist, in Healthy Volunteers. Public Library of Science (PLoS).
MLA (9th ed.) CitationWohlford, George F., et al. A Phase 1 Clinical Trial of SP16, a First-in-class Anti-inflammatory LRP1 Agonist, in Healthy Volunteers. Public Library of Science (PLoS).
Warning: These citations may not always be 100% accurate.